Medical News Today
A variant form of a common growth factor, called VEGF (vascular endothelial growth factor) was identified that is responsible for the inflammation and altered retinal vascularisation that occurs in diseases such as diabetic retinopathy (DR). It could become the target for novel therapies that will help to solve, or at least to ease, a pathology which is poorly treatable by common drugs.